Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%

Jul.29.2025
Australia’s “OurFutures” vaping education program cut student vaping rates by 65% after 12 months, according to a trial of 5,000 students across 40 schools. Published in The Lancet, it is the first proven effective school-based e-health intervention in Australia. The program will be expanded through 2028, with long-term data expected in 2026.

Key Points:

 

·Project results: The "Our Futures Vaping Prevention Education program" in Australia has significantly reduced the likelihood of teenagers using e-cigarettes, with students involved in the program being 65% less likely to use e-cigarettes 12 months later compared to students who did not participate. 

 

·Research background: The program is funded by the current Australian government and is the first confirmed school-based electronic health intervention program in Australia that can prevent teenagers from using e-cigarettes. 

 

·Research methods: The randomized controlled trial involved 40 schools and over 5000 students, with the results published in The Lancet. 

 

·Project content: The program engages students through cartoon stories, quizzes, and classroom activities, co-designed by young people and teachers to align with national curriculum guidelines. 

 

·Public health significance: The latest data shows a decline in young people using e-cigarettes, with e-cigarette use being increasingly viewed as uncool and socially unacceptable among youth. 

 

·Future plans: The project will be expanded nationwide until 2028, with long-term tracking data expected to be available by 2026.

 


 

【2Firsts News Flash】According to the official website of the Australian government on July 29th, Australia's "Our Futures Vaping Prevention Education program" implemented in schools has achieved tangible results in preventing young people from using e-cigarettes.

 

This randomized controlled trial involved over 5,000 students from 40 schools, and its results were published on July 29th in the top health journal, The Lancet. The study found that students who participated in the program were 65% less likely to use e-cigarettes after 12 months compared to students who did not take part in the course. Additionally, 80% of students reported that the knowledge they gained would help them deal with e-cigarette-related situations in the future.

 

This project is funded by the current Australian government through the Medical Research Future Fund and the National Health and Medical Research Council. It is the first Australian school-based electronic health intervention program proven to prevent adolescents from using e-cigarettes.

 

This program attracts students and delivers information through cartoon stories, quizzes, and classroom activities. It is designed by young people and teachers together to align with the national curriculum.

 

These positive findings are consistent with the latest data on "Generation Vape," which shows a decreasing trend in youth e-cigarette use. E-cigarettes are increasingly being seen as uncool and socially unacceptable among young people.

 

"Our Future" e-cigarette project will be rolled out nationwide until 2028, with long-term tracking data expected to be available by 2026.

 

All high schools are eligible to register and participate in this project, and can do so by signing up immediately.

 

Minister Butler's statement:

 

"'Our Future' e-cigarette prevention education program is helping Australian teenagers make wise choices and resist e-cigarettes. It is smart, scalable, and evidence shows it is effective. This is the evidence-based prevention action we need to protect children's health. Young people are moving away from e-cigarettes. They see its nature - harmful, addictive, and pushed by big tobacco companies. This is proof of the power of education, community, and strong government action."

 

According to publicly available information, The Lancet is one of the oldest and most respected peer-reviewed medical journals in the world, alongside the New England Journal of Medicine, JAMA (Journal of the American Medical Association), and the British Medical Journal, often referred to as the "Big Four" international medical journals.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
JNR has introduced the Shisha Hookah 70K, a high-capacity rechargeable disposable vape designed around a hookah-inspired experience. The device comes prefilled with 60ml of e-liquid at 6mg/ml (0.6%) nicotine strength, alongside a 1,000mAh rechargeable battery and a 0.38Ω single mesh coil. It also features adjustable airflow and battery and e-liquid level displays. JNR claims the device can deliver up to 70,000 puffs and offers more than 20 flavors. Retail listings for the product have appeared in markets including Tunisia.
Market
Aug.24 by 2Firsts Perspectives
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
According to CBS Los Angeles on August 27, 2026, California lawmakers have passed Assembly Bill 762, which would phase out disposable, battery-embedded nicotine vapes in the state. If signed by Governor Gavin Newsom, manufacturing and importation of the covered products would be prohibited beginning January 1, 2027, followed by a sales ban on January 1, 2028. Driven primarily by concerns over electronic waste, lithium-battery fires and environmental pollution, the legislation would further shift California’s legal vape market toward rechargeable, refillable or replaceable-pod devices.
Aug.28
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
China’s vape-related exports reached $1.047 billion in July 2026, up 16.5% year on year and the highest monthly total of the year. Growth was heavily concentrated in the U.S., where exports jumped 53.5% to $404 million and accounted for 94.9% of the overall increase. Exports to all other markets rose just 1.2%. By category, nicotine-containing non-combustible products—primarily vapes—under HS24041200 rose 24.7% and generated 95.5% of the total increase. Vape-device exports under HS85434000 fell 0.4%, while other nicotine-substitute products under HS24041990 grew 88.9% but remained comparatively small.
DATA
Aug.24
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
ITC Infotech has expanded its multi-year strategic technology partnership with British American Tobacco (BAT), providing technology services across Poland, Romania and India while continuing to support BAT's newly launched Future Capabilities Centre in India and existing technology hubs in Malaysia and Mexico. The companies said the agreement will focus on AI-enabled innovation, technology capability building and greater operational efficiency. The partnership also aligns with BAT's broader Fit2Win transformation programme, under which the group is expanding the use of external technology and business-services partners to simplify its global operating model.
Aug.13
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
KIWI has launched the Spark 2 and Spark 2 Pro refillable pod systems in Germany at official prices of €18 and €29, respectively. Spark 2 uses an 800mAh removable lithium-ion battery in a pen-style body, while Spark 2 Pro features a 1,400mAh removable battery, a box-shaped design and vibration feedback every 20 puffs. Both devices use the same 2ml Spark V2 pods in 0.8Ω and 1.2Ω versions, with AirSync airflow adjustment and a choice between Cotton Tips and conventional Drip Tips. The new pods also remain compatible with the original KIWI Spark.
News
Sep.29 by 2Firsts Perspectives